Development and validation of a preoperative model for predicting positive proximal margins in adenocarcinoma of the esophagogastric junction and assessing safe margin distance

被引:0
作者
Guo, Zhenjiang [1 ]
Wang, Ning [2 ]
Zhao, Guangyuan [1 ]
Du, Liqiang [1 ]
Cui, Zhaobo [2 ]
Liu, Fangzhen [1 ]
机构
[1] Hengshui Peoples Hosp, Dept Gastrointestinal, Hengshui, Hebei, Peoples R China
[2] Hengshui Peoples Hosp, Dept Resp & Crit Care Med, Hengshui, Hebei, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
esophagogastric Junction; adenocarcinoma; advanced; positive proximal margin; predictive model; GASTRIC-CANCER; GASTROESOPHAGEAL JUNCTION; ESOPHAGEAL CANCER; PROGNOSTIC IMPACT; DIAGNOSIS; RESECTION; GUIDELINES; MANAGEMENT; CARDIA;
D O I
10.3389/fonc.2024.1503728
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To develop and validate a model for preoperative prediction of positive proximal margins for adenocarcinoma of the esophagogastric junction (AEG) by transabdominal approach, and to analyze the safe margin distances for patients with different risks of positive proximal margins. Materials and methods: A retrospective analysis was performed on 284 AEG patients who underwent surgery via the transabdominal approach at Hengshui People's Hospital between January 2017 and December 2023. Patients were divided into a training set (n=201, first five years) and a test set (n=83, last two years). Clinicopathologic factors potentially influencing margin status were collected. The synthetic minority oversampling technique (SMOTE) was applied to address class imbalance in the training set. Two nomogram models were developed: one based on the original training set and the other using the SMOTE dataset. The model's performance was compared using the test set, with the area under the curve (AUC) used to evaluate discrimination and the Hosmer-Lemeshow test used for model fit. The best-performing model was used to calculate total scores for the entire cohort, and the optimal cutoff value was determined via the ROC curve. Patients were classified into low- and high-risk groups based on the total score, and optimal margin distances were determined using Youden's index. Results: The model developed using the SMOTE dataset showed superior AUC for predicting positive proximal margins in the test set compared to the model based on the original training set (0.814 vs. 0.780). Independent predictors of positive proximal margins included Borrmann classification, Lauren classification, cT stage, tumor differentiation, and Siewert classification. The Hosmer-Lemeshow test showed a good model fit (chi(2) = 5.397, P = 0.612). Using a cutoff total score of 206.811, patients were divided into low-risk (score < 206.811) and high-risk (score >= 206.811) groups, with an AUC of 0.788. For the low-risk group, a proximal margin distance of 2.75 cm yielded an AUC of 0.824, with a sensitivity of 54.5%, specificity of 97.9%, and a Youden's index of 0.524. For the high-risk group, a margin distance of 3.85 cm provided an AUC of 0.813, sensitivity of 73.1%, specificity of 80.0%, and a Youden's index of 0.531. Conclusions: The nomogram may offer a valuable preoperative tool for assessing the risk of positive proximal margins in AEG patients. While it holds the potential to inform surgical decision-making and help determine appropriate margin distances, further validation in larger and more diverse cohorts is needed to confirm its clinical utility.
引用
收藏
页数:9
相关论文
共 40 条
  • [1] Gastric Cancer, Version 2.2022
    Ajani, Jaffer A.
    D'Amico, Thomas A.
    Bentrem, David J.
    Chao, Joseph
    Cooke, David
    Corvera, Carlos
    Das, Prajnan
    Enzinger, Peter C.
    Enzler, Thomas
    Fanta, Paul
    Farjah, Farhood
    Gerdes, Hans
    Gibson, Michael K.
    Hochwald, Steven
    Hofstetter, Wayne L.
    Ilson, David H.
    Keswani, Rajesh N.
    Kim, Sunnie
    Kleinberg, Lawrence R.
    Klempner, Samuel J.
    Lacy, Jill
    Ly, Quan P.
    Matkowskyj, Kristina A.
    McNamara, Michael
    Mulcahy, Mary F.
    Outlaw, Darryl
    Park, Haeseong
    Perry, Kyle A.
    Pimiento, Jose
    Poultsides, George A.
    Reznik, Scott
    Roses, Robert E.
    Strong, Vivian E.
    Su, Stacey
    Wang, Hanlin L.
    Wiesner, Georgia
    Willett, Christopher G.
    Yakoub, Danny
    Yoon, Harry
    McMillian, Nicole
    Pluchino, Lenora A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : 167 - 192
  • [2] Guidelines for the management of oesophageal and gastric cancer
    Allum, William H.
    Blazeby, Jane M.
    Griffin, S. Michael
    Cunningham, David
    Jankowski, Janusz A.
    Wong, Rachel
    [J]. GUT, 2011, 60 (11) : 1449 - 1472
  • [3] Global burden of oesophageal and gastric cancer by histology and subsite in 2018
    Arnold, Melina
    Ferlay, Jacques
    Henegouwen, Mark I. van Berge
    Soerjomataram, Isabelle
    [J]. GUT, 2020, 69 (09) : 1564 - 1571
  • [4] Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)
    Baba, Eishi
    Terashima, Masanori
    Fujishiro, Mitsuhiro
    [J]. GASTRIC CANCER, 2023, 26 (01) : 1 - 25
  • [5] Adenocarcinoma of the gastroesophageal junction - Influence of esophageal resection margin and operative approach on outcome
    Barbour, Andrew P.
    Rizk, Nabil P.
    Gonen, Mithat
    Tang, Laura
    Bains, Manjit S.
    Rusch, Valerie W.
    Coit, Daniel G.
    Brennan, Murray F.
    [J]. ANNALS OF SURGERY, 2007, 246 (01) : 1 - 8
  • [6] Association of Positive Transection Margins with Gastric Cancer Survival and Local Recurrence
    Bickenbach, K. A.
    Gonen, M.
    Strong, V.
    Brennan, M. F.
    Coit, D. G.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (08) : 2663 - 2668
  • [7] Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study
    Bissolati, Massimiliano
    Desio, Matteo
    Rosa, Fausto
    Rausei, Stefano
    Marrelli, Daniele
    Baiocchi, Gian Luca
    De Manzoni, Giovanni
    Chiari, Damiano
    Guarneri, Giovanni
    Pacelli, Fabio
    De Franco, Lorenzo
    Molfino, Sarah
    Cipollari, Chiara
    Orsenigo, Elena
    [J]. GASTRIC CANCER, 2017, 20 (01) : 70 - 82
  • [8] SMOTE for high-dimensional class-imbalanced data
    Blagus, Rok
    Lusa, Lara
    [J]. BMC BIOINFORMATICS, 2013, 14
  • [9] Celli R, 2018, AM J CLIN PATHOL, V150, P353, DOI [10.1093/AJCP/AQY062, 10.1093/ajcp/aqy062]
  • [10] Chen L, 2022, Zhonghua Wai Ke Za Zhi, V60, P813, DOI 10.3760/cma.j.cn112139-20220424-00181